OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
JKAG56

JK Agri Genetics Ltd

Fishing & FarmingVerified

The company's capital structure is characterized by a low debt-to-equity ratio of 0.03, indicating a conservative leverage profile. Total liabilities amount to INR 1,898.12 million, while total equity stands at INR 1,074.81 million. The current ratio of 1.23 suggests moderate liquidity, with current assets slightly exceeding current liabilities. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. Profitability metrics show a challenging performance. The company reported a net loss of INR 25.09 million and an operating loss of INR 627.76 million. Return on equity (ROE) is negative at -2.33%, and return on assets (ROA) is also negative at -0.84%. These figures indicate that the company is not generating returns for its shareholders or effectively utilizing its assets to generate profit. Geographically, the company's revenue is concentrated in India, as disclosed in its business description. The company operates in a single segment, Agri and Allied Products, and does not report revenue by geographic regions. This concentration may expose the company to regional economic and regulatory risks. The company's growth trajectory is uncertain. Revenue for the latest period is INR 1,617.87 million, but there is no disclosed growth rate or outlook for the current or next fiscal year. The lack of positive revenue growth and the presence of operating and net losses suggest that the company is not currently expanding its market share or improving its financial performance. Risk factors include a medium liquidity risk, as indicated by the current ratio and negative net cash position. The company's dilution risk is assessed as low, with no significant dilution sources identified in the risk assessment. However, the operating loss and negative ROE suggest that the company may need to raise additional capital in the future, which could lead to dilution. Recent events and filings do not provide specific details on the company's strategic initiatives or financial developments. The company's financial snapshot and risk assessment do not include recent events or transcripts, making it difficult to assess any recent changes in the company's operations or financial position.

30-day price · JKAG+27.60 (+8.8%)
Low$290.20High$379.00Close$342.50As of15 May, 00:00 UTC
Profile
CompanyJK Agri Genetics Ltd
TickerJKAG.BO
SectorConsumer Non-Cyclicals
BusinessFood & Beverages
Industry groupFood & Beverages
IndustryFishing & Farming
AI analysis

Business. JK Agri Genetics Limited is an India-based seed processing company engaged in the research, production, processing, and marketing of hybrid seeds for crops such as bajra, sorghum, rice, cotton, maize, and vegetables, as well as plant nutrients products.

Classification. The company is classified under the Consumer Non-Cyclicals economic sector, Food & Beverages business sector, and Fishing & Farming industry, with a confidence level of 0.92.

The company's capital structure is characterized by a low debt-to-equity ratio of 0.03, indicating a conservative leverage profile. Total liabilities amount to INR 1,898.12 million, while total equity stands at INR 1,074.81 million. The current ratio of 1.23 suggests moderate liquidity, with current assets slightly exceeding current liabilities. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. Profitability metrics show a challenging performance. The company reported a net loss of INR 25.09 million and an operating loss of INR 627.76 million. Return on equity (ROE) is negative at -2.33%, and return on assets (ROA) is also negative at -0.84%. These figures indicate that the company is not generating returns for its shareholders or effectively utilizing its assets to generate profit. Geographically, the company's revenue is concentrated in India, as disclosed in its business description. The company operates in a single segment, Agri and Allied Products, and does not report revenue by geographic regions. This concentration may expose the company to regional economic and regulatory risks. The company's growth trajectory is uncertain. Revenue for the latest period is INR 1,617.87 million, but there is no disclosed growth rate or outlook for the current or next fiscal year. The lack of positive revenue growth and the presence of operating and net losses suggest that the company is not currently expanding its market share or improving its financial performance. Risk factors include a medium liquidity risk, as indicated by the current ratio and negative net cash position. The company's dilution risk is assessed as low, with no significant dilution sources identified in the risk assessment. However, the operating loss and negative ROE suggest that the company may need to raise additional capital in the future, which could lead to dilution. Recent events and filings do not provide specific details on the company's strategic initiatives or financial developments. The company's financial snapshot and risk assessment do not include recent events or transcripts, making it difficult to assess any recent changes in the company's operations or financial position.
Key takeaways
  • The company has a low debt-to-equity ratio, indicating a conservative capital structure.
  • Profitability is weak, with negative returns on equity and assets.
  • Revenue is concentrated in a single geographic region and business segment.
  • Liquidity is moderate, but the company has a negative net cash position.
  • Growth prospects are unclear due to the absence of disclosed revenue growth rates or outlooks.
  • Dilution risk is currently low, but the company may need to raise capital in the future.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$1.62B
Gross profit$613.0M
Operating income-$627.8M
Net income-$25.1M
R&D
SG&A
D&A
SBC
Operating cash flow$34.2M
CapEx
Free cash flow$15.3M
Total assets$2.97B
Total liabilities$1.90B
Total equity$1.07B
Cash & equivalents
Long-term debt$32.0M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.07B
Net cash-$32.0M
Current ratio1.2
Debt/Equity0.0
ROA-0.8%
ROE-2.3%
Cash conversion-1.4%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food · cohort 445 companies
MetricJKAGActivity
Op margin-38.8%3.2% medp25 3.2% · p75 3.2%bottom quartile
Net margin-1.6%2.1% medp25 2.1% · p75 2.1%bottom quartile
Gross margin37.9%9.2% medp25 9.2% · p75 9.2%top quartile
CapEx / revenue-3.9% medp25 -9.9% · p75 -1.1%
Debt / equity3.0%8.7% medp25 8.7% · p75 8.7%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 09:51 UTC#5cd03e83
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 09:53 UTCJob: 9d0dd83e